Maximising the efficiency of clinical screening programmes: balancing predictive genetic testing with a right not to know

We explored the dilemma between patients' right not to know their genetic status and the efficient use of health-care resources in the form of clinical cancer screening programmes. Currently, in the Netherlands, 50% risk carriers of heritable cancer syndromes who choose not to know their geneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuurman, Agnes G, van der Kolk, Dorina M, Verkerk, Marian A, Birnie, Erwin, Ranchor, Adelita V, Plantinga, Mirjam, van Langen, Irene M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538217/
https://www.ncbi.nlm.nih.gov/pubmed/25564039
http://dx.doi.org/10.1038/ejhg.2014.269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538217/
https://www.ncbi.nlm.nih.gov/pubmed/25564039
http://dx.doi.org/10.1038/ejhg.2014.269

Ejemplares similares